Our Blog
See below for an opinion on current matters around the world.
Is the new price right?: HTA takes a back seat to broader price negotiations
Could Human HTA Committees be Replaced with AI Systems?
WFH ... WTF ... ????: Working-from-home, employer reaction and pandemic-inspired industrial changes
Ghosts in the Machine: the search for productivity measures in health technology assessment
More ‘us’ and less ‘them’ thinking: a plea for 2024
Déjà vu all over again?: Australia’s industrial policy debate
Universal Health Coverage at the Half-Way Point: Political Disappointment & Business Opportunity
Have health and the PBS come of age as the Intergenerational Report turns 21?
Unconscious uncoupling?: Three years on Covid-19 is no longer a global emergency
The Magic, Myths & Fantasy of ESG: What Does it Mean for Pharma?
From the sublime to the ridiculous: 5 years of Shawview Consulting blogs
Species extinction in Australia: time for a wake-up call
Lessons learned: finance and resilience in post-COVID health systems
Jane Fonda, mix tapes & Australia's 5% discount rate: when time, health economics and ethics collide
It’s the economy, stupid: the economic benefits of health spending
Australians now understand there is a 'queue' for new health technologies
A little less conversation, a little more action please: the global state of AMR
What would Dr Who say?: Time travel and the macroeconomic impact of COVID-19
The economist, the activist and the epiphany: an argument about efficiency in health spending
Creeping Through the Backdoor: Disruption in Medicine and Health